Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Oyster Point Pharma, Inc. (OYST)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Oyster Point Pharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Oyster Point Pharma, Inc. since 2005.
The reporting company's ticker symbol is OYST. The reporting company's CIK number is 1720725.
The total value of stock buying since 2005 is $53,924,800.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-04||Kkr Associates Hcsg L.p.||Buy||155,000||16.00||2,480,000|
|2019-11-04||Lochner Daniel (Chief Financial Officer)||Buy||6,300||16.00||100,800|
|2019-11-04||Nau Jeffrey (President and CEO)||Buy||1,000||16.00||16,000|
|2019-11-04||Snisarenko John (Chief Commercial Officer)||Buy||3,000||16.00||48,000|
|2019-11-04||Ozawa Clare (Director)||Buy||562,500||16.00||9,000,000|
|2019-11-04||Vida Ventures, Llc||Buy||185,000||16.00||2,960,000|
|2019-11-04||Kkr Fund Holdings Gp Ltd||Buy||155,000||16.00||2,480,000|
|2019-11-04||Versant Side Fund Iv, L.p. (10% Owner)||Buy||590,000||16.00||9,440,000|
|2019-11-04||Sandell Scott D (10% Owner)||Buy||935,000||16.00||14,960,000|
|2019-11-04||Link William J Phd (Director)||Buy||27,500||16.00||440,000|
|2019-11-04||Lainovic Sacha (Director)||Buy||750,000||16.00||12,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises of OYST listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Oyster Point Pharma, Inc. (symbol OYST, CIK number 1720725) see the Securities and Exchange Commission (SEC) website.